Vanja De Weerd
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Longitudinal genome-wide aneuploidy measurements in circulating cell-free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer.
Journal: Molecular oncology
Published: November 10, 2025
Interrelation between lncRNA HOTAIR and EZH2 expression and progression free survival during endocrine treatment in breast cancer.
Journal: BMC cancer
Published: November 06, 2025
Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases.
Journal: EBioMedicine
Published: October 21, 2025
Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort.
Journal: The British journal of surgery
Published: September 08, 2025
Improved circulating tumor DNA profiling by simultaneous extraction of DNA methylation and copy number information from methylated DNA sequencing data.
Journal: NPJ precision oncology
Published: May 27, 2025
Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study.
Journal: EClinicalMedicine
Published: March 26, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial.
Journal: Nature medicine
Published: February 24, 2025
Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 24, 2025
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer.
Journal: Breast cancer research : BCR
Published: November 22, 2024
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.
Journal: Molecular oncology
Published: July 25, 2024
Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer.
Journal: JCO precision oncology
Published: December 07, 2023
A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis.
Journal: The journal of applied laboratory medicine
Published: November 23, 2023
Last Updated: 09/26/2026